inopathy. Treatment approaches for DME have shifted away from Laser therapy as the first line of therapy for
DME.
Aim and objectives: to investigate the changes in Optical coherence tomography angiography (OCT-A) after
suprachoroidal injection of triamcinolone acetonide (SCTA) in patients with diabetic macular edema.
Patients and Methods: This a prospective case series study that was conducted on twenty eyes with refractory
diabetic macular edema who treated with single suprachoroidal injection of triamcinolone acetonide. All patients
underwent history taking, ocular examination and optical coherence tomography angiography (OCT-Angiography).
Results: there was no statistically significant difference between the studied groups as regard (Relation between
baseline, third month and sixth month LogMAR BCVA), (Relation between baseline, third month and sixth month
CFT (Central foveal thickness)), (Relation between baseline, third month, sixth month SVD (superficial vessel
density) and sixth month DVD (Deep vessel density)), (Relation between baseline, third month and sixth month FAZ
(Foveal avascular zone) in mm) and (Correlation between BCVA at six month and (CFT, SVD, DVD, FAZ) at six
months).
Conclusion: our findings suggest that SCTA may be an effective treatment option for diabetic macular edema,
improving visual outcomes and reducing retinal thickness.